Correlation Between Calidi Biotherapeutics and TransAKT

Can any of the company-specific risk be diversified away by investing in both Calidi Biotherapeutics and TransAKT at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Calidi Biotherapeutics and TransAKT into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Calidi Biotherapeutics and TransAKT, you can compare the effects of market volatilities on Calidi Biotherapeutics and TransAKT and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Calidi Biotherapeutics with a short position of TransAKT. Check out your portfolio center. Please also check ongoing floating volatility patterns of Calidi Biotherapeutics and TransAKT.

Diversification Opportunities for Calidi Biotherapeutics and TransAKT

-0.11

Correlation Coefficient

Calidi Biotherapeutics  TransAKT

Good diversification

The 3 months correlation between Calidi and TransAKT is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Calidi Biotherapeutics and TransAKT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TransAKT and Calidi Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Calidi Biotherapeutics are associated (or correlated) with TransAKT. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TransAKT has no effect on the direction of Calidi Biotherapeutics i.e., Calidi Biotherapeutics and TransAKT go up and down completely randomly.

Pair Corralation between Calidi Biotherapeutics and TransAKT

Given the investment horizon of 90 days Calidi Biotherapeutics is expected to under-perform the TransAKT. But the stock apears to be less risky and, when comparing its historical volatility, Calidi Biotherapeutics is 9.03 times less risky than TransAKT. The stock trades about -0.23 of its potential returns per unit of risk. The TransAKT is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.30  in TransAKT on July 19, 2025 and sell it today you would earn a total of  0.11  from holding TransAKT or generate 36.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Calidi Biotherapeutics  vs.  TransAKT

Calidi Biotherapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Calidi Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in November 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

TransAKT

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in TransAKT are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent forward-looking signals, TransAKT exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Calidi Biotherapeutics and TransAKT

The main advantage of trading using opposite Calidi Biotherapeutics and TransAKT positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Calidi Biotherapeutics position performs unexpectedly, TransAKT can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TransAKT will offset losses from the drop in TransAKT's long position.

The idea behind Calidi Biotherapeutics and TransAKT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.